Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Related Citations for PubMed (Select 19558668)

1.

Large sharing networks and unusual injection practices explain the rapid rise in HIV among IDUs in Sargodha, Pakistan.

Khan AA, Awan AB, Qureshi SU, Razaque A, Zafar ST.

Harm Reduct J. 2009 Jun 26;6:13. doi: 10.1186/1477-7517-6-13.

2.

Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.

Emmanuel F, Fatima M.

Int J Drug Policy. 2008 Apr;19 Suppl 1:S59-64. doi: 10.1016/j.drugpo.2007.12.012. Epub 2008 Feb 20.

PMID:
18281206
3.

Profiles of risk: a qualitative study of injecting drug users in Tehran, Iran.

Razzaghi EM, Movaghar AR, Green TC, Khoshnood K.

Harm Reduct J. 2006 Mar 18;3:12.

4.

Designing an experimental HIV/HCV intervention to promote the safe re-use of drug preparation materials by injection drug users in Puerto Rico.

Finlinson HA, Colón HM, Negrón J, Robles RR.

Harm Reduct J. 2008 Apr 28;5:14. doi: 10.1186/1477-7517-5-14.

5.

Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users.

Vickerman P, Hickman M, Rhodes T, Watts C.

J Acquir Immune Defic Syndr. 2006 Jul;42(3):355-61.

PMID:
16645549
6.

Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.

Vickerman P, Hickman M, Judd A.

Int J Epidemiol. 2007 Apr;36(2):396-405. Epub 2007 Jan 11.

7.

Factors associated with an explosive HIV epidemic among injecting drug users in Sargodha, Pakistan.

Emmanuel F, Archibald C, Razaque A, Sandstrom P.

J Acquir Immune Defic Syndr. 2009 May 1;51(1):85-90. doi: 10.1097/QAI.0b013e31819906f3.

PMID:
19289969
8.

Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.

Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Rüütel K, Des Jarlais DC.

Harm Reduct J. 2009 Feb 20;6:3. doi: 10.1186/1477-7517-6-3.

9.

Drug choice, spatial distribution, HIV risk, and HIV prevalence among injection drug users in St. Petersburg, Russia.

Kruse GR, Barbour R, Heimer R, Shaboltas AV, Toussova OV, Hoffman IF, Kozlov AP.

Harm Reduct J. 2009 Jul 31;6:22. doi: 10.1186/1477-7517-6-22.

10.

Rapid assessment and response to injecting drug use in Madras, south India.

Kumar MS, Mudaliar S, Thyagarajan SP, Kumar S, Selvanayagam A, Daniels D.

Int J Drug Policy. 2000 Mar 1;11(1-2):83-98.

PMID:
10699546
11.

Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001.

Des Jarlais DC, McKnight C, Friedmann P.

J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S73-6.

PMID:
12489620
12.

High risk behaviors of injection drug users registered with harm reduction programme in Karachi, Pakistan.

Altaf A, Shah SA, Zaidi NA, Memon A, Nadeem-ur-Rehman, Wray N.

Harm Reduct J. 2007 Feb 10;4:7.

13.

Estimating the level of HIV prevention coverage, knowledge and protective behavior among injecting drug users: what does the 2008 UNGASS reporting round tell us?

Mathers BM, Degenhardt L, Adam P, Toskin I, Nashkhoev M, Lyerla R, Rugg D.

J Acquir Immune Defic Syndr. 2009 Dec;52 Suppl 2:S132-42. doi: 10.1097/QAI.0b013e3181baf0c5.

PMID:
19901626
14.

Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study.

Vazirian M, Nassirimanesh B, Zamani S, Ono-Kihara M, Kihara M, Ravari SM, Gouya MM.

Harm Reduct J. 2005 Oct 7;2:19.

15.

High prevalence of HIV infection among injection drug users (IDUs) in Hyderabad and Sukkur, Pakistan.

Altaf A, Saleem N, Abbas S, Muzaffar R.

J Pak Med Assoc. 2009 Mar;59(3):136-40.

PMID:
19288936
16.

The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis.

Kwon JA, Iversen J, Maher L, Law MG, Wilson DP.

J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):462-9. doi: 10.1097/QAI.0b013e3181a2539a.

PMID:
19387355
18.

HIV prevalence and risk behaviours among injecting drug users in six indonesian cities implications for future HIV prevention programs.

Morineau G, Bollen LJ, Syafitri RI, Nurjannah N, Mustikawati DE, Magnani R.

Harm Reduct J. 2012 Sep 3;9:37. doi: 10.1186/1477-7517-9-37.

19.

Access to syringes in three Russian cities: implications for syringe distribution and coverage.

Sarang A, Rhodes T, Platt L.

Int J Drug Policy. 2008 Apr;19 Suppl 1:S25-36. doi: 10.1016/j.drugpo.2007.11.008. Epub 2008 Mar 3.

PMID:
18313910
20.

High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan.

Kuo I, ul-Hasan S, Galai N, Thomas DL, Zafar T, Ahmed MA, Strathdee SA.

Harm Reduct J. 2006 Aug 16;3:26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk